morpholino based antisense oligomer (Ohio State University/Ohio State University Technology Commercialization and Knowledge Transfer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemorpholino based antisense oligomer (Ohio State University/Ohio State University Technology Commercialization and Knowledge Transfer)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsMuscular Atrophy, Spinal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Ohio State University
Active IndicationsN/A
Inactive IndicationsMuscular Atrophy, Spinal

Other Information

ATC CodeN/A
Related LinksN/A